8 Analysts Have This to Say About IDEAYA Biosciences
Portfolio Pulse from Benzinga Insights
IDEAYA Biosciences (NASDAQ:IDYA) has received positive analyst ratings in the last quarter, with 2 bullish and 6 somewhat bullish ratings. The average 12-month price target for IDYA is $39.88, which is a 7.2% increase from the previous target of $37.20. The high estimate is $44.00 and the low is $32.00. Analysts rate stocks based on research and may provide forecasts for various financial metrics.
November 30, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IDEAYA Biosciences has received a majority of positive ratings from analysts, with an increased average price target suggesting a bullish outlook for the stock.
The positive analyst ratings and the increase in the average price target indicate a strong bullish sentiment towards IDYA. This could lead to a short-term increase in the stock price as investors react to the analysts' optimistic views.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100